[{"StockholdersEquityConverted_0_Q2_USD":325606000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-171769000.0,"CommonStockSharesOutstanding_0_Q2_shares":122251258.0,"StockholdersEquity_0_Q2_USD":265759000.0,"EarningsPerShareBasic_1_Q2_USD":-1.03,"EarningsPerShareBasic_2_Q2_USD":-1.81,"Assets_0_Q2_USD":905227000.0,"CommonStockSharesConverted_0_Q2_shares":124665939.0,"NetIncomeLossConverted_1_Q2_USD":-121034000.0,"NetIncomeLossConverted_2_Q2_USD":-212884000.0,"Ticker":"BBIO","CIK":"1743881","name":"BRIDGEBIO PHARMA, INC.","OfficialName":"BridgeBio Pharma Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1594164456.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200811"}]